2-BROMOPHENYL ISOTHIOCYANATE | CAS:13037-60-0

We serve 2-BROMOPHENYL ISOTHIOCYANATE CAS:13037-60-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-BROMOPHENYL ISOTHIOCYANATE

Chemical Name:2-BROMOPHENYL ISOTHIOCYANATE
CAS.NO:13037-60-0
Synonyms:2-BROMOPHENYL ISOTHIOCYANATE
1-bromo-2-isothiocyanatobenzene
Isothiocyanic Acid 2-Bromophenyl Ester
2-BroMophenyl Isothiocyanate
 
Physical and Chemical Properties:
Density 1.591
Boiling Point 257 °C
Melting Point 20 °C
Molecular Formula C7H4BrNS
Molecular Weight 214.08200
Flash Point >110°C
 
Specification:
Appearance:Light yellow liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-BROMOPHENYL ISOTHIOCYANATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-BroMophenyl Isothiocyanate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isothiocyanic Acid 2-Bromophenyl Ester Use and application,2-BroMophenyl Isothiocyanate technical grade,usp/ep/jp grade.


Related News: Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.ACRYLIC ACID TETRADECYL ESTER manufacturer This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.Dimethyl oxalate supplier Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.5-(2-chloroethyl)-2,3-dihydro-1-benzofuran vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.